ORALAIR alternatives

ORALAIR contains five grasses in one tablet while single-grass products target only Timothy or ragweed. This makes ORALAIR suitable for patients allergic to multiple northern grasses, whereas single-grass tablets may be preferred when testing confirms one primary allergen.

Yes, many patients move to subcutaneous immunotherapy when sublingual tablets cause oral side effects. Allergy shots require weekly clinic visits initially but cover a broader range of allergens and do not involve daily home dosing.

No sublingual tablet including ORALAIR is approved under age 5. Younger children are typically managed with antihistamines, nasal steroids, or avoidance until they reach the approved age range for immunotherapy tablets or shots.

Compounded drops are customized but lack the large-scale trials supporting ORALAIR's 3-year benefit data. ORALAIR offers standardized dosing and FDA approval while drops vary by pharmacy and may not include epinephrine requirements.

All sublingual immunotherapy tablets carry the same boxed warning and epinephrine requirement. Only traditional symptom medications like antihistamines avoid this, though they do not provide the disease-modifying effect of ORALAIR.